Pfizer Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 09/27/2023

Stock Rating
3
Price Target
$52.65
Consensus
Outperform
Upside
62.60%
Analysts
8
Stock Rating
3
Upside
62.60%
Analysts
8
Price Target
$52.65

Pfizer Inc Stock Forecast and Price Target

The average target price for Pfizer Inc's stock set by eight renowned analysts in recent months is $52.65, representing a potential upside of approximately 62.6% from its last closing price if met by 2024. This estimation is based on a high estimate of $75.00 and a low estimate of $44.00. If you are looking to invest in the stock, it's important to research and compare different companies.

$52.65

62.60% Upside

Outperform
Outperform

Pfizer Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Price has grown by 89.49%, from $36.70 to $69.54. 19 analysts predict Pfizer Inc's Fair Value will decrease by 2.33% in the next year, reaching $67.92. By 2030, professionals predict that Pfizer Inc's Fair Value will decrease by 42.04%, to $40.31.

2023 Fair Value Forecast
$67.92
2024 Fair Value Forecast
$56.10
2025 Fair Value Forecast
$53.99
2026 Fair Value Forecast
$52.50
2027 Fair Value Forecast
$52.87
2028 Fair Value Forecast
$43.42
2029 Fair Value Forecast
$40.31
2030 Fair Value Forecast
$40.31
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly & Co Outperform 14
$550.01 Buy/Sell $333.19 -27.27%
JNJ Stock Forecast Johnson & Johnson Outperform 10
$159.02 Buy/Sell $179.95 13.51%
MRK Stock Forecast Merck Outperform 5
$105.39 Buy/Sell $99.57 11.97%
BMY Stock Forecast Bristol-Myers Squibb Co Outperform 2
$58.54 Buy/Sell $80.99 41.78%
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 13
$351.69 Buy/Sell $384.26 -7.30%

Pfizer Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Revenue has grown by 145.28%, from $40.91B to $100.33B. 17 analysts predict Pfizer Inc's Revenue will decrease by 20.35% in the next year, reaching $79.92B. By 2030, professionals predict that Pfizer Inc's Revenue will decrease by 47.10%, to $53.07B.

2023 Rev Forecast
$79.92B
2024 Rev Forecast
$69.26B
2025 Rev Forecast
$67.30B
2026 Rev Forecast
$65.06B
2027 Rev Forecast
$64.48B
2028 Rev Forecast
$55.63B
2029 Rev Forecast
$53.31B
2030 Rev Forecast
$53.07B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ZTS Stock Forecast Zoetis Inc Outperform 18
$176.87 Buy/Sell $209.70 15.90%
REGN Stock Forecast Regeneron Pharmaceuticals Inc Outperform 2
$832.41 Buy/Sell $796.73 -6.06%
BAX Stock Forecast Baxter International Inc Outperform 17
$37.32 Buy/Sell $60.73 55.41%

Pfizer Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Dividend per Share has grown from $1.44 to $1.64 – a 13.89% increase. Next year, analysts are expecting Dividend per Share to reach $1.68 – an increase of 2.44%. Over the next eight years, the forecast is for Dividend per Share to grow by 3.05%.

2023 DPS Forecast
$1.68
2024 DPS Forecast
$1.72
2025 DPS Forecast
$1.77
2026 DPS Forecast
$1.72
2027 DPS Forecast
$1.67
2028 DPS Forecast
$1.67
2029 DPS Forecast
$1.67
2030 DPS Forecast
$1.69
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$175.15 Buy/Sell $244.18 43.31%
VTRS Stock Forecast Viatris Inc Hold 8
$9.72 Buy/Sell $13.70 38.89%
UTHR Stock Forecast United Therapeutics Corp Outperform 12
$230.00 Buy/Sell $280.69 28.26%

Pfizer Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Free Cash Flow has grown by 309684947.88%, rising from $10.54B to $32647.00T. The next year, 7 experts forecast that Pfizer Inc's Free Cash Flow will decrease by 100.00%, reaching $30.67B. In 2030, professionals predict that Pfizer Inc's Free Cash Flow will decrease by 100.00%, reaching $15.21B.

2023 FCF Forecast
$30.67B
2024 FCF Forecast
$24.18B
2025 FCF Forecast
$23.37B
2026 FCF Forecast
$22.93B
2027 FCF Forecast
$21.67B
2028 FCF Forecast
$16.77B
2029 FCF Forecast
$15.65B
2030 FCF Forecast
$15.21B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CTLT Stock Forecast Catalent Inc Hold 15
$45.63 Buy/Sell $83.92 59.98%
IONS Stock Forecast Ionis Pharmaceuticals Inc Outperform 9
$46.28 Buy/Sell $52.42 8.04%
NEOG Stock Forecast Neogen Hold 16
$18.61 Buy/Sell $37.00 37.02%

Pfizer Inc Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Net Income has grown by 95.98%, rising from $16.03B to $31.41B. For next year, analysts predict Net Income of $31.82B, which would mean an increase of 1.32%. According to professionals, by 2030, Pfizer Inc's Net Income will have decreased by 40.08%, falling down to $18.82B.

2023 NI Forecast
$31.82B
2024 NI Forecast
$25.70B
2025 NI Forecast
$24.66B
2026 NI Forecast
$23.88B
2027 NI Forecast
$23.83B
2028 NI Forecast
$20.02B
2029 NI Forecast
$18.84B
2030 NI Forecast
$18.82B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BCPC Stock Forecast Balchem Outperform 18
$123.57 Buy/Sell $163.67 32.72%
CYTK Stock Forecast Cytokinetics Inc Outperform 10
$29.98 Buy/Sell $62.67 100.13%
TGTX Stock Forecast TG Therapeutics Outperform 9
$8.77 Buy/Sell $73.38 116.65%

Pfizer Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's EBITDA has grown, rising from $13.86B to $43.64B – a growth of 214.92%. According to the 10 analysts polled, in the next year, Pfizer Inc's EBITDA will fall by 14.50%, reaching $37.31B. By 2030, professionals believe that Pfizer Inc's EBITDA will have decreased by 55.44%, falling to $19.44B.

2023 EBITDA Forecast
$37.31B
2024 EBITDA Forecast
$31.16B
2025 EBITDA Forecast
$29.88B
2026 EBITDA Forecast
$29.39B
2027 EBITDA Forecast
$29.07B
2028 EBITDA Forecast
$22.41B
2029 EBITDA Forecast
$19.65B
2030 EBITDA Forecast
$19.44B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INDV Stock Forecast Indivior PLC Buy 14
£21.64 Buy/Sell £3.79 -78.10%
PCRX Stock Forecast Pacira BioSciences Outperform 16
$33.20 Buy/Sell $79.67 134.94%
CORT Stock Forecast Corcept Therapeutics Outperform 16
$32.47 Buy/Sell $0.00 -9.15%

Pfizer Inc EBIT Forecast for 2023 - 2025 - 2030

Pfizer Inc's EBIT has grown In the last two years, rising from $8.14B to $26.85B – a growth of 229.71%. In the next year, analysts believe that EBIT will reach $33.76B – an increase of 25.78%. By 2030, professionals believe that Pfizer Inc's EBIT will decrease by 19.82%, reaching $21.52B – a concerning trend for the company.

2023 EBIT Forecast
$33.76B
2024 EBIT Forecast
$27.33B
2025 EBIT Forecast
$27.59B
2026 EBIT Forecast
$26.95B
2027 EBIT Forecast
$27.08B
2028 EBIT Forecast
$22.66B
2029 EBIT Forecast
$21.42B
2030 EBIT Forecast
$21.52B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$45.51 Buy/Sell $41.00 -3.32%
IRWD Stock Forecast Ironwood Pharmaceuticals Hold 14
$8.53 Buy/Sell $12.60 46.54%
SUPN Stock Forecast Supernus Pharmaceuticals Outperform 16
$30.06 Buy/Sell $35.50 13.11%

Pfizer Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's EPS has grown by 89.49%, from $2.95 to $5.59. 19 analysts predict Pfizer Inc's EPS will decrease by 2.33% in the next year, reaching $5.46. By 2030, professionals predict that Pfizer Inc's EPS will decrease by 42.04%, to $3.24.

2023 EPS Forecast
$5.46
2024 EPS Forecast
$4.51
2025 EPS Forecast
$4.34
2026 EPS Forecast
$4.22
2027 EPS Forecast
$4.25
2028 EPS Forecast
$3.49
2029 EPS Forecast
$3.24
2030 EPS Forecast
$3.24
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LGND Stock Forecast Ligand Pharmaceuticals Outperform 14
$60.21 Buy/Sell $195.43 163.25%
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$148.91 Buy/Sell $170.08 17.52%
USNA Stock Forecast USANA Health Sciences Hold 14
$58.47 Buy/Sell $104.00 -2.51%